TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE Drug Patent Profile

Which patents cover Trandolapril And Verapamil Hydrochloride, and when can generic versions of Trandolapril And Verapamil Hydrochloride launch?

Trandolapril And Verapamil Hydrochloride is a drug marketed by Glenmark Generics and is included in one NDA.

The generic ingredient in TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE is trandolapril; verapamil hydrochloride. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trandolapril; verapamil hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Trandolapril And Verapamil Hydrochloride

A generic version of TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE was approved as trandolapril; verapamil hydrochloride by GLENMARK GENERICS on May 5^th, 2010.

Summary for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	5
Patent Applications:	2
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE?	TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE excipients list
DailyMed Link:	TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE at DailyMed

Recent Clinical Trials for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Hospital Authority, Hong Kong	Phase 4
Assaf-Harofeh Medical Center
Mario Negri Institute for Pharmacological Research	Phase 3

See all TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE clinical trials

Pharmacology for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

Drug Class	Angiotensin Converting Enzyme Inhibitor Calcium Channel Blocker
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors Calcium Channel Antagonists Cytochrome P450 3A Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

C08DA	Phenylalkylamine derivatives
C08D	SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS
C08	CALCIUM CHANNEL BLOCKERS
C	Cardiovascular system

C09AA	ACE inhibitors, plain
C09A	ACE INHIBITORS, PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Generics	TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE	trandolapril; verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	079135-004	Aug 30, 2010		RX	No	No
Glenmark Generics	TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE	trandolapril; verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	079135-003	May 5, 2010		RX	No	Yes
Glenmark Generics	TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE	trandolapril; verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	079135-001	May 26, 2010		RX	No	No
Glenmark Generics	TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE	trandolapril; verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	079135-002	May 26, 2010		RX	No	No